Quest Diagnostics ( NYSE: DGX ) announced an agreement to acquire select assets of University Hospitals' outreach laboratory services business. The transaction will broaden access in Ohio to Quest's test menu, network of convenient patient access sites and broad health plan coverage, the company said. The parties expect to complete the transaction in the fourth quarter of 2024.
DGX +3.33% premarket to $155.94.
Source: Press Release More on Quest Diagnostics Quest Diagnostics: Beat Down After Beating Q2 Estimates Quest Diagnostics prices $1.85B senior notes Quest Diagnostics beats top-line and bottom-line estimates; raises FY24 revenue, EPS outlook.
